HealthMore in Health→
Biotech IPO Window Reopens With Three Offerings and a Strong Debut
Key Takeaways
- Endpoints says three biotech IPOs priced in the same Thursday-to-Friday window.
- The combined proceeds exceeded $850 million.
- The companies named are Seaport Therapeutics, Hemab Therapeutics, and Avalyn.
- Avalyn rose strongly in its Nasdaq debut, suggesting renewed investor appetite.
DE
DT Editorial Team··via endpoints.news